FORM 8-K

Company

NRX Pharmaceuticals, Inc.

Filed

February 23, 2023

Period of Report

February 16, 2023

Accession Number

0000950142-23-000510

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →